We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
+0.52%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$15.3B
AUM Growth
+$933M
(+6.5%)
Cap. Flow
+$1.09B
Cap. Flow
% of AUM
7.1%
Top 10 Holdings %
Top 10 Hldgs %
20.85%
Holding
1,816
New
17
Increased
573
Reduced
1,124
Closed
101
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$111M |
| 2 |
Amazon
AMZN
|
+$95.9M |
| 3 |
Microsoft
MSFT
|
+$91.8M |
| 4 |
Roper Technologies
ROP
|
+$69.8M |
| 5 |
PX
Praxair Inc
PX
|
+$68.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Brown-Forman Class B
BF.B
|
+$28.4M |
| 2 |
Becton Dickinson
BDX
|
+$28M |
| 3 |
W.W. Grainger
GWW
|
+$20.5M |
| 4 |
Lowe's Companies
LOW
|
+$15M |
| 5 |
Target
TGT
|
+$10.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.5% |
| 2 | Financials | 13.66% |
| 3 | Healthcare | 12.92% |
| 4 | Consumer Discretionary | 10.42% |
| 5 | Industrials | 10.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Eli Lilly
LLY
$1.07T
| $14.9M | 0.1% |
192,342
+5,256
| +3% | +$423K |
|
177
American International
AIG
$41.9B
| $14.8M | 0.1% |
272,205
+10,488
| +4% | +$620K |
|
178
BioMarin Pharmaceuticals
BMRN
$11.4B
| $14.8M | 0.1% |
182,630
+7,010
| +4% | +$602K |
|
|
XLNX
179
DELISTED
Xilinx Inc
XLNX
| $14.7M | 0.1% |
204,135
+34,173
| +20% | +$2.46M |
|
180
Salesforce
CRM
$134B
| $14.7M | 0.1% |
126,645
-27,065
| -18% | -$3.11M |
|
181
KLA
KLAC
$280B
| $14.7M | 0.1% |
1,348,510
+200,590
| +17% | +$2.23M |
|
182
Gen Digital
GEN
$15.7B
| $14.3M | 0.09% |
554,448
+176,590
| +47% | +$4.8M |
|
183
Idexx Laboratories
IDXX
$42.9B
| $14.1M | 0.09% |
73,923
+10,872
| +17% | +$2.01M |
|
184
Accenture
ACN
$89.5B
| $14M | 0.09% |
90,927
+2,771
| +3% | +$439K |
|
185
Progressive
PGR
$125B
| $14M | 0.09% |
228,974
+9,862
| +5% | +$563K |
|
|
MRSH
186
Marsh
MRSH
$85.5B
| $13.8M | 0.09% |
167,511
+6,413
| +4% | +$531K |
|
187
Prudential Financial
PRU
$41.5B
| $13.6M | 0.09% |
131,614
+4,249
| +3% | +$479K |
|
188
Thermo Fisher Scientific
TMO
$207B
| $13.6M | 0.09% |
65,758
+1,745
| +3% | +$366K |
|
189
Wynn Resorts
WYNN
$10.2B
| $13.5M | 0.09% |
74,190
+12,773
| +21% | +$2.21M |
|
|
MDP
190
DELISTED
Meredith Corporation
MDP
| $13.2M | 0.09% |
245,065
-63,976
| -21% | -$3.8M |
|
191
Allstate
ALL
$66.9B
| $13M | 0.08% |
137,277
+5,077
| +4% | +$492K |
|
192
Tootsie Roll Industries
TR
$2.85B
| $12.9M | 0.08% |
553,812
-82,429
| -13% | -$2.14M |
|
193
Nektar Therapeutics
NKTR
$2.38B
| $12.6M | 0.08% |
7,890
+165
| +2% | +$213K |
|
|
STI
194
DELISTED
SunTrust Banks, Inc.
STI
| $12.6M | 0.08% |
184,796
+4,535
| +3% | +$315K |
|
195
Seagate
STX
$199B
| $12.5M | 0.08% |
212,842
+32,002
| +18% | +$1.7M |
|
196
CVS Health
CVS
$137B
| $12.3M | 0.08% |
198,019
+6,502
| +3% | +$467K |
|
197
Public Storage
PSA
$60.1B
| $12.3M | 0.08% |
61,194
+308
| +0.5% | +$60K |
|
198
Truist Financial
TFC
$63.4B
| $12.2M | 0.08% |
234,862
+5,993
| +3% | +$323K |
|
199
Lockheed Martin
LMT
$133B
| $12.2M | 0.08% |
35,961
+964
| +3% | +$328K |
|
200
Occidental Petroleum
OXY
$56.8B
| $12.1M | 0.08% |
185,696
+1,169
| +0.6% | +$81.8K |
|
Similar funds
ProShare Advisors's Q1 2018 Portfolio in Review
As of Q1 2018, ProShare Advisors held 1,816 positions worth $15.3B, up 6.5% from $14.4B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
ProShare Advisors deployed $1.09B of net new capital in Q1 2018, opening 17 new positions and adding to 573 existing holdings. Its largest new stake was CoStar Group: 93,260 shares worth $3.38M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Brown-Forman Class B, an estimated $28.4M trimmed.
- ProShare Advisors's largest Q1 2018 buy was CoStar Group: 93,260 shares worth $3.38M.
- ProShare Advisors added most to Apple in Q1 2018, an estimated $111M increase.
- ProShare Advisors's biggest Q1 2018 reduction was Brown-Forman Class B, cutting an estimated $28.4M.
- ProShare Advisors fully exited Bioverativ Inc. Common Stock in Q1 2018, selling an estimated $3.8M.
- ProShare Advisors's ten largest holdings make up 21% of its $15.3B portfolio in Q1 2018.
- ProShare Advisors opened 17 new positions and closed 101 in Q1 2018.
- ProShare Advisors's portfolio value rose 6.5% quarter-over-quarter to $15.3B.
Based on ProShare Advisors's 13F filing for Q1 2018, filed 14 May 2018.